About this trial
Lung ultrasound is an increasingly valuable diagnostic tool in neonatal intensive care due to its safety and accessability.
This pilot study investigates whether a quantitative approach - the heterogeneity index, previously only used in fetal lung assessment - can enhance the diagnostic accuracy of neonatologist-performed lung ultrasound (NPLUS). The index will be calculated from raw ultrasound images of preterm and term neonates and compared with conventional lung ultrasound scores to evaluate its clinical relevance.
Eligibility criteria
Qualifiers
Preterm neonates born between 28+0 and 36+6 weeks of gestation and term-born neonates (> 37+0 weeks of gestation) admitted to the NICU
Presence of respiratory distress requiring respiratory support (invasive and non-invasive) at the timepoint of NPLUS 1.
Written informed consent obtained from the parents prior to the measurement.
Disqualifiers
cardiopulmonary malformations
pleural effusion
pneumothorax
Trial design
Treatments tested in this trial
- Not listed